«LYUTETSIY-177 (177Lu-PSMA-617) bilan nishonlangan prostata uchun maxsus membranli antigen, in'ektsiya uchun»
Yuqori radiokimyoviy unumdorllikga ega va yuqori radiokimyoviy, kimyoviy tozalikga hamda yuqori solishtirma radioaktivlikga ega tashuvchisiz lutetsiy-177 radionklidi asosidagi radofarmasevtik dori vositasini olish texnologiyasini yaratishdan iborat.
Metastatik
kastratsiyaga chidamli prostata bezi saratonini erta tashxislash va davolash
uchun «Lutaprost–[PSMA–617]» liofilizat shaklida radiofarmasevtik kompositsiyasini hamda
PSMA-617 peptid-ligandini 177Lu radionuklidi bilan yuqori unumdorlik bilan
nishonlab «Lutaprost-[(177Lu)-PSMA-617]»
RFPlarini olish
O'ZBEKISTON RESPUBLIKASI FANLAR AKADEMIYASI YADRO FIZIKASI INSTITUTI
InnoWeek.Uz serves as a platform for local and international research centers, investment funds, technology agencies, technoparks, and business incubators. It has been held regularly since 2021...